No one could have predicted the extent to which the COVID-19 pandemic would erode decades of progress in global public health, and the world is still reeling from the shock.
However, we have the opportunity — and the duty — to learn the right lessons to mitigate the ongoing pandemic, while minimizing the risk of similar events in the future.
Although there are new threats on the horizon, we must not allow our focus to move away from COVID-19. The pandemic highlighted significant gaps in the global health systems. To leave them unaddressed would be bad public policy and bad economics, because there can never be a trade-off between health and economic development.
Illustration: Yusha
COVID-19 has demonstrated that health is central to development, prosperity and national security.
The pandemic’s disruption of health services has resulted in spikes in HIV, tuberculosis, malaria and many noncommunicable diseases, including unreported cases and deaths. These are diseases that the world had previously made great gains toward controlling.
Making matters worse, the pandemic has led to decreased life expectancy, lower basic immunization coverage, and increased psychosocial and mental health challenges.
Compounding the pandemic’s painful legacy, the war in Ukraine has triggered an extensive humanitarian crisis, endangered global food supplies, increased food and energy prices, and threatens to cause recession and economic hardship around the world.
The IMF in September said that “the impact of higher import costs for food and fertilizer for those highly exposed to food insecurity will add US$9 billion to their balance of payments pressures — in 2022 and 2023. This will erode countries’ international reserves, and their ability to pay for food and fertilizer imports.”
Moreover, higher interest rates and tightening financial conditions have raised the specter of widespread debt distress in low and middle-income countries. By subjecting public finances to great strain, recent global shocks have put vital, long-term health investment at risk.
Global solidarity and equity are the underpinnings of any effective response to the challenges we face. We must advance on three fronts to preserve the central role that health systems — and more precisely primary healthcare — play at all times, and especially when economic crises hit.
First, investment in primary healthcare must increase, because investment gaps in health widen during difficult times such as we are experiencing now. These gaps, in turn, increase the risks people face from global threats. It is in everybody’s interest to help all countries that lack resources to invest sufficiently in health system resilience, as well as pandemic preparation and response.
Second, innovation in life sciences needs more financing, especially to scale it up in a sustainable manner. This means supporting local production or mental health service delivery innovations that reach millions of people and are incorporated into the primary healthcare system.
Third, multilateral organizations should collaborate to prepare us all to confront future health threats more effectively. Here, initiatives such as a legally binding pandemic accord, developed and ratified by countries and rooted in the WHO constitution, can provide the desperately needed playbook for preventing and responding to pandemics.
Unfortunately, even before COVID-19, the world was lagging in the race to meet globally agreed health targets, including many of those enshrined in the UN’s Sustainable Development Goals for 2030. The pandemic has set us back further.
In times of rising debt and increasing risks to debt sustainability, governments, international organizations and financial institutions must cooperate closely to get us back on track. While illustrating the many shortcomings in global cooperation, COVID-19 has also demonstrated the importance of working together.
That is why our two organizations have committed to combining our strengths to promote and increase investments in health.
For example, with support from the European Investment Bank (EIB), the WHO, the Wellcome Trust and others, the AMR Action Fund is investing in innovative solutions to tackle antimicrobial resistance and ensure that there is a pipeline of new drugs to address key needs.
The scientific community has identified antimicrobial resistance as “the silent pandemic” and a serious threat to global health and development.
Moreover, we are working to channel additional resources from other partners, such as the European Commission, development finance institutions and the private sector, to boost health services where they are needed most.
Earlier this year, we announced a partnership, in cooperation with the European Commission and the African Union, to strengthen health systems, in particular primary healthcare, in Africa.
The EIB has pledged to make at least 500 million euros (US$520.7 million) available to mobilize more than 1 billion euros in investment, with a particular focus on primary healthcare in Sub-Saharan Africa.
New cooperative projects are already moving ahead in Africa and the Middle East. In Rwanda, the WHO is to directly advise the government on rebuilding the country’s National Health Laboratory, with financing from the European Commission and the EIB. The new laboratory is to perform more than 80,000 tests each year, serving a population of more than 12 million.
To have a measurable impact in these countries, we focus on using innovative finance mechanisms that spur domestic funding and promote our shared goal of health for all. At the same time, we are committed to promoting sustainability in debt management, so that our partner countries’ investments in health do not result in financial pain. Again, to invest in health is to promote good economic policy.
Good health and well-being are goals the whole world shares. To accelerate the deployment of innovative health solutions, countries and institutions must work together, fostering cooperation not only between states, but also between governments and the private sector.
Werner Hoyer is president of the European Investment Bank. Tedros Adhanom Ghebreyesus is director-general of the WHO.
Copyright: Project Syndicate
Recently, China launched another diplomatic offensive against Taiwan, improperly linking its “one China principle” with UN General Assembly Resolution 2758 to constrain Taiwan’s diplomatic space. After Taiwan’s presidential election on Jan. 13, China persuaded Nauru to sever diplomatic ties with Taiwan. Nauru cited Resolution 2758 in its declaration of the diplomatic break. Subsequently, during the WHO Executive Board meeting that month, Beijing rallied countries including Venezuela, Zimbabwe, Belarus, Egypt, Nicaragua, Sri Lanka, Laos, Russia, Syria and Pakistan to reiterate the “one China principle” in their statements, and assert that “Resolution 2758 has settled the status of Taiwan” to hinder Taiwan’s
Singaporean Prime Minister Lee Hsien Loong’s (李顯龍) decision to step down after 19 years and hand power to his deputy, Lawrence Wong (黃循財), on May 15 was expected — though, perhaps, not so soon. Most political analysts had been eyeing an end-of-year handover, to ensure more time for Wong to study and shadow the role, ahead of general elections that must be called by November next year. Wong — who is currently both deputy prime minister and minister of finance — would need a combination of fresh ideas, wisdom and experience as he writes the nation’s next chapter. The world that
Can US dialogue and cooperation with the communist dictatorship in Beijing help avert a Taiwan Strait crisis? Or is US President Joe Biden playing into Chinese President Xi Jinping’s (習近平) hands? With America preoccupied with the wars in Europe and the Middle East, Biden is seeking better relations with Xi’s regime. The goal is to responsibly manage US-China competition and prevent unintended conflict, thereby hoping to create greater space for the two countries to work together in areas where their interests align. The existing wars have already stretched US military resources thin, and the last thing Biden wants is yet another war.
Since the Russian invasion of Ukraine in February 2022, people have been asking if Taiwan is the next Ukraine. At a G7 meeting of national leaders in January, Japanese Prime Minister Fumio Kishida warned that Taiwan “could be the next Ukraine” if Chinese aggression is not checked. NATO Secretary-General Jens Stoltenberg has said that if Russia is not defeated, then “today, it’s Ukraine, tomorrow it can be Taiwan.” China does not like this rhetoric. Its diplomats ask people to stop saying “Ukraine today, Taiwan tomorrow.” However, the rhetoric and stated ambition of Chinese President Xi Jinping (習近平) on Taiwan shows strong parallels with